Monsenso A/S Stock

Equities

MONSO

DK0061277977

IT Services & Consulting

Market Closed - Nasdaq Copenhagen 10:54:38 2024-04-24 am EDT 5-day change 1st Jan Change
0.44 DKK +4.76% Intraday chart for Monsenso A/S +2.33% +52.25%
Sales 2022 6.21M 892K Sales 2023 9.62M 1.38M Capitalization 8.83M 1.27M
Net income 2022 -7M -1M Net income 2023 -5M -718K EV / Sales 2022 1.72 x
Net cash position 2022 572K 82.09K Net cash position 2023 1.81M 260K EV / Sales 2023 0.73 x
P/E ratio 2022
-1.38 x
P/E ratio 2023
-1.52 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 95.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.76%
1 week+2.33%
Current month-5.38%
1 month-15.38%
3 months+58.27%
6 months+56.58%
Current year+52.25%
More quotes
1 week
0.38
Extreme 0.38
0.44
1 month
0.35
Extreme 0.35
0.60
Current year
0.27
Extreme 0.272
0.64
1 year
0.18
Extreme 0.1815
0.64
3 years
0.18
Extreme 0.1815
10.70
5 years
0.18
Extreme 0.1815
28.00
10 years
0.18
Extreme 0.1815
28.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 15-02-01
Founder 56 13-10-10
Director of Finance/CFO - 20-08-02
Members of the board TitleAgeSince
Chairman 64 22-03-31
Founder 56 13-10-10
Founder - -
More insiders
Date Price Change Volume
24-04-24 0.44 +4.76% 19,585
24-04-23 0.42 +5.00% 75,000
24-04-22 0.4 -2.91% 8,968
24-04-19 0.412 -5.50% 50,767
24-04-18 0.436 +1.40% 1,169

Delayed Quote Nasdaq Copenhagen, April 24, 2024 at 10:54 am EDT

More quotes
MONSENSO A/S is a Denmark-based medical software developer. The Company’s provides SaaS, cloud-based solution that connects people with mental disorders and their relatives or caregivers with their clinician (therapist or physician) for the purpose of increased data collection, collaboration and communication. MONSENSO A/S develops possibilities for health prevention, early intervention, and psychological disorders treatments.
More about the company

Annual profits - Rate of surprise